CEN BIOTECH, INC.
January 8, 2016
Suzanne Hayes, Assistant Director
Office of Healthcare and Insurance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
CEN Biotech, Inc. (the “Company” or “CEN”)
Form 10-12G, Amendment 1
File No.: 000-55557
Dear Ms. Hayes:
We are filing Amendment One to our Form 10-12G to clarify the record and distribution date for the anticipated spinoff of shares.
If you have any questions or require anything further, please feel free to call me at 226-344-0660.
Sincerely,
/s/Bill Chaaban
Bill Chaaban
President
1